Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Blog - Page 162

Blog

ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trials
COVID-19 | FDA | Pharmaceutical | Therapeutics

ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trials

On Apr. 21, 2020, BioSig Technologies announced that subsidiary ViralClear Pharmaceuticals, had submitted an application for Vicromax(tm) (merimepodib,…

Read More ViralClear submited application for Vicromax through FDAs Coronavirus Treatment Acceleration Program for accelerated clinical trialsContinue

Tyson Fresh Meats resumed limited operations at Columbus Junction Pork Plant
COVID-19 | Life Science History

Tyson Fresh Meats resumed limited operations at Columbus Junction Pork Plant

On Apr. 21, 2020, Tyson Fresh Meats resumed limited operations at its pork plant in Columbus Junction, Iowa,…

Read More Tyson Fresh Meats resumed limited operations at Columbus Junction Pork PlantContinue

OpGen subsidiary Curetis GmbH and Karolinska Institutet collaborated in study of bacterial Co-infections in COVID-19 pneumonia patients
COVID-19 | Life Science History

OpGen subsidiary Curetis GmbH and Karolinska Institutet collaborated in study of bacterial Co-infections in COVID-19 pneumonia patients

On Apr. 21, 2020, OpGen announced the start of an investigator initiated collaboration with Karolinska Institutet, Sweden, to…

Read More OpGen subsidiary Curetis GmbH and Karolinska Institutet collaborated in study of bacterial Co-infections in COVID-19 pneumonia patientsContinue

LabCorp COVID-19 at-home test kit received FDA Emergency Use Authorization
COVID-19 | FDA | Life Science History

LabCorp COVID-19 at-home test kit received FDA Emergency Use Authorization

On Apr. 21, 2020, LabCorpᆴ announced it has received an Emergency Use Authorization (EUA) from the FDA. The…

Read More LabCorp COVID-19 at-home test kit received FDA Emergency Use AuthorizationContinue

Quest Diagnostics began performing COVID-19 antibody testing
COVID-19 | Life Science History

Quest Diagnostics began performing COVID-19 antibody testing

On Apr. 21, 2020, Quest Diagnostics announced that it has begun to perform antibody testing for coronavirus (COVID-19)…

Read More Quest Diagnostics began performing COVID-19 antibody testingContinue

More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital participate in a pioneering study
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital participate in a pioneering study

On Apr. 21, 2020, Rutgers University announced it has launched the nation’s largest prospective study of health care…

Read More More than 800 employees from Rutgers, Robert Wood Johnson University Hospital and University Hospital participate in a pioneering studyContinue

New virus detection process under development at Rutgers-Camden
COVID-19 | Life Science History

New virus detection process under development at Rutgers-Camden

On Apr. 21, 2020,the fight against the coronavirus is underway in a Rutgers UniversityヨCamden research laboratory, where chemistry…

Read More New virus detection process under development at Rutgers-CamdenContinue

Todos Medical announced FDA Emergency Use Authorization allowed for Gnomegen COVID-19 PCR test kits
Biotechnology | COVID-19 | Diagnostics | FDA | Therapeutics

Todos Medical announced FDA Emergency Use Authorization allowed for Gnomegen COVID-19 PCR test kits

On Apr. 21, 2020, Todos Medical announced that Gnomegen has received Emergency Use Authorization from the FDA for…

Read More Todos Medical announced FDA Emergency Use Authorization allowed for Gnomegen COVID-19 PCR test kitsContinue

Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patients
COVID-19 | Life Science History

Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patients

On Apr. 21, 2020, Immunic reported that its lead asset, IMU-838, a selective oral DHODH inhibitor successfully demonstrated…

Read More Immunic reported that IMU-838 demonstrated Preclinical activity against SARS-CoV-2 and explores plans for phase 2 clinical trial in COVID-19 patientsContinue

Cleveland Clinic and SAS shared COVID-19 predictive models to help hospitals plan for current and future needs
COVID-19 | Diagnostics | Medical Device | Medicine | Therapeutics

Cleveland Clinic and SAS shared COVID-19 predictive models to help hospitals plan for current and future needs

On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…

Read More Cleveland Clinic and SAS shared COVID-19 predictive models to help hospitals plan for current and future needsContinue

Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virus
Biotechnology | COVID-19 | Therapeutics

Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virus

On Apr. 21, 2020, Pharnext and the University Hospital Institute Mediterranee Infection in France, announced a new joint…

Read More Pharnext and University Hospital Institute Mediterranee Infection announce effort to evaluate repurposed drugs for potential use against COVID-19 virusContinue

Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients

On Apr. 20, 2020, Novartis announced it had reached an agreement with the U.S. Food and Drug Administration…

Read More Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patientsContinue

RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19
Biotechnology | NIH | Therapeutics

RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19

On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…

Read More RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19Continue

USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles County
Biotechnology | COVID-19 | Diagnostics

USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles County

On Apr. 20, 2020, University of Southern California (USC) and the Los Angeles County Department of Public Health…

Read More USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles CountyContinue

Oxford University project assessed Coronavirus infection rates in children and teenagers across UK
Biotechnology | COVID-19 | Diagnostics

Oxford University project assessed Coronavirus infection rates in children and teenagers across UK

On Apr. 20, 2020, a multi-site project, called ‘What’s the STORY?’ received funding from UK Research and Innovation…

Read More Oxford University project assessed Coronavirus infection rates in children and teenagers across UKContinue

Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeutics

On Apr. 20, 2020, Anixa Biosciences announced it had entered into a strategic collaboration with OntoChem GmbH to…

Read More Anixa Biosciences and OntoChem announced collaboration to develop novel COVID-19 therapeuticsContinue

Alexion announced plans to initiate phase 3 study of ULTOMIRISᆴ (ravulizumab-cwvz) in hospitalized patients with severe COVID-19
COVID-19 | FDA | Life Science History

Alexion announced plans to initiate phase 3 study of ULTOMIRISᆴ (ravulizumab-cwvz) in hospitalized patients with severe COVID-19

On Apr. 20, 2020, Alexion announced plans to initiate a global Phase 3 study to investigate ULTOMIRISᆴ (ravulizumab-cwvz)…

Read More Alexion announced plans to initiate phase 3 study of ULTOMIRISᆴ (ravulizumab-cwvz) in hospitalized patients with severe COVID-19Continue

Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19
COVID-19 | FDA | Life Science History

Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19

On Apr. 20, 2020, Innovation Pharma reported that based on molecular screening of 11,552 compounds comprising already FDA-approved…

Read More Screening of 11,552 compounds identified Innovation Pharma’s Brilacidin as promising Potential inhibitors of novel Coronavirus COVID-19Continue

IDEXX made pet test for COVID-19 Virus available to veterinarians
Biotechnology | COVID-19 | Diagnostics | Therapeutics | Veterinary

IDEXX made pet test for COVID-19 Virus available to veterinarians

On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….

Read More IDEXX made pet test for COVID-19 Virus available to veterinariansContinue

Deison Technology Park provided increased capacity for VGXI to manufacture vaccines
Life Science History | Vaccine

Deison Technology Park provided increased capacity for VGXI to manufacture vaccines

On Apr. 20, 2020, VGX signed as the first occupant of Conroeメs Deison Technology Park and will move…

Read More Deison Technology Park provided increased capacity for VGXI to manufacture vaccinesContinue

Rice University  COVID-19 research fund awarded first grants
Biotechnology | COVID-19 | Diagnostics | Therapeutics

Rice University COVID-19 research fund awarded first grants

On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…

Read More Rice University COVID-19 research fund awarded first grantsContinue

Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE study
COVID-19 | FDA | Life Science History

Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE study

On Apr. 20, 2020, Atossa Therapeutics announced that it had applied to the FDA for approval to commence…

Read More Atossa Therapeutics submitted Clinical Investigation approval to FDA for launch of COVID-19 HOPE studyContinue

The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options
CDC | COVID-19 | Life Science History | NIH

The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment options

On Apr. 17, 2020, the NIH and the Foundation for the NIH are bringing together more than a…

Read More The NIH launched a public-private partnership to speed COVID-19 vaccine and treatment optionsContinue

Antiviral remdesivir prevented disease progression in monkeys with COVID-19
COVID-19 | NIH | Therapeutics

Antiviral remdesivir prevented disease progression in monkeys with COVID-19

On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…

Read More Antiviral remdesivir prevented disease progression in monkeys with COVID-19Continue

FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer
Biotechnology | Disease | FDA | Oncology | Therapeutics

FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer

On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…

Read More FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancerContinue

Five Oxford University COVID-19 projects received UK Research and Innovation funding
COVID-19 | Non-Profit Research | Therapeutics | Vaccine

Five Oxford University COVID-19 projects received UK Research and Innovation funding

On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…

Read More Five Oxford University COVID-19 projects received UK Research and Innovation fundingContinue

Roche developed new serology test to detect COVID-19 antibodies
Biotechnology | COVID-19 | Diagnostics

Roche developed new serology test to detect COVID-19 antibodies

On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…

Read More Roche developed new serology test to detect COVID-19 antibodiesContinue

Kaiser Permanente Washington announced Coronavirus vaccine trial to include older people
COVID-19 | Non-Profit Research | Vaccine

Kaiser Permanente Washington announced Coronavirus vaccine trial to include older people

On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…

Read More Kaiser Permanente Washington announced Coronavirus vaccine trial to include older peopleContinue

Sinovac announced commencement of phase I human clinical trial for vaccine candidate against COVID-19
COVID-19 | Vaccine

Sinovac announced commencement of phase I human clinical trial for vaccine candidate against COVID-19

On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…

Read More Sinovac announced commencement of phase I human clinical trial for vaccine candidate against COVID-19Continue

FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.
COVID-19 | FDA | Medical Device | Therapeutics

FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.

On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…

Read More FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.Continue

Page navigation

Previous PagePrevious 1 … 160 161 162 163 164 … 346 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search